DK1519944T3 - Fremgangsmåder til fremstilling af fibrinogen - Google Patents

Fremgangsmåder til fremstilling af fibrinogen

Info

Publication number
DK1519944T3
DK1519944T3 DK03738326.2T DK03738326T DK1519944T3 DK 1519944 T3 DK1519944 T3 DK 1519944T3 DK 03738326 T DK03738326 T DK 03738326T DK 1519944 T3 DK1519944 T3 DK 1519944T3
Authority
DK
Denmark
Prior art keywords
methods
fibrinogen
preparing fibrinogen
preparing
purification
Prior art date
Application number
DK03738326.2T
Other languages
English (en)
Inventor
Sarah Kingsland
Robert Clemmitt
David Evans
Peter Feldman
Original Assignee
Nhs Blood & Transplant
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nhs Blood & Transplant filed Critical Nhs Blood & Transplant
Application granted granted Critical
Publication of DK1519944T3 publication Critical patent/DK1519944T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK03738326.2T 2002-07-10 2003-07-07 Fremgangsmåder til fremstilling af fibrinogen DK1519944T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0216001.8A GB0216001D0 (en) 2002-07-10 2002-07-10 Process and composition
PCT/GB2003/002928 WO2004007533A1 (en) 2002-07-10 2003-07-07 Processes for the preparation of fibrinogen

Publications (1)

Publication Number Publication Date
DK1519944T3 true DK1519944T3 (da) 2010-03-29

Family

ID=9940203

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03738326.2T DK1519944T3 (da) 2002-07-10 2003-07-07 Fremgangsmåder til fremstilling af fibrinogen

Country Status (17)

Country Link
US (1) US7816495B2 (da)
EP (1) EP1519944B1 (da)
JP (1) JP4324102B2 (da)
AT (1) ATE449104T1 (da)
AU (1) AU2003244850B2 (da)
BR (1) BRPI0312521B8 (da)
CA (1) CA2491716C (da)
DE (1) DE60330146D1 (da)
DK (1) DK1519944T3 (da)
EC (1) ECSP055584A (da)
ES (1) ES2332780T3 (da)
GB (1) GB0216001D0 (da)
IL (1) IL165988A0 (da)
MX (1) MXPA05000395A (da)
NO (1) NO20050091L (da)
PL (1) PL210616B1 (da)
WO (1) WO2004007533A1 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004009400A1 (de) 2004-02-24 2005-09-08 Zlb Behring Gmbh Fibrinogen Reinigung
DE102004037805B3 (de) * 2004-08-03 2006-03-23 Zlb Behring Gmbh Verfahren zur Hitzebehandlung fibrinogenhaltiger pharmazeutischer Zubereitungen
US20080176789A1 (en) 2004-08-27 2008-07-24 Novc Nordisk Healthcare A/G Purification of Factor Xlll Polypeptides From Biological Materials
ES2378777T3 (es) 2004-11-23 2012-04-17 Zymogenetics, Inc. Purificación del factor XIII humano recombinante
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
CN101067131B (zh) * 2007-04-30 2011-08-17 华南理工大学 一种利用亲和层析法分离纯化纤溶酶的方法
JP6244079B2 (ja) * 2008-04-21 2017-12-06 ノボ ノルディスク ヘルス ケア アーゲー 乾燥トランスグルタミナーゼ組成物
US8945895B2 (en) 2009-07-31 2015-02-03 Baxter International Inc. Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof
WO2012038410A1 (en) 2010-09-20 2012-03-29 Octapharma Ag Process for production of fibrinogen
MX351340B (es) 2012-03-13 2017-10-11 Octapharma Ag Proceso mejorado para la produccion de fibrinogeno y fibrinogeno producido por este.
US9243239B2 (en) 2012-03-26 2016-01-26 The Regents Of The University Of Colorado, A Body Corporate Purification of cystathionine beta-synthase
US10188965B2 (en) 2012-12-05 2019-01-29 Csl Behring Gmbh Hydrophobic charge induction chromatographic depletion of a protein from a solution
US20140154233A1 (en) 2012-12-05 2014-06-05 Csl Limited Method of purifying therapeutic proteins
US9675678B2 (en) 2013-01-29 2017-06-13 The Regents Of The University Of Colorado, A Body Corporate Compositions and methods for treatment of homocystinuria
US9932388B2 (en) 2014-11-13 2018-04-03 Hemarus Therapeutics Limited Chromatographic process for producing high purity fibrinogen and thrombin
EP3373922B1 (en) 2015-11-09 2022-01-05 The Regents of The University of Colorado, A Body Corporate Compositions and methods for use in the treatment of homocystinuria
JP6943858B2 (ja) 2015-12-23 2021-10-06 フェニックス ティシュー リペア インコーポレイテッドＰｈｏｅｎｉｘ Ｔｉｓｓｕｅ Ｒｅｐａｉｒ，Ｉｎｃ． コラーゲン７組成物及びそれを用いる方法
EP3612214A4 (en) 2017-04-17 2021-01-20 The Regents of the University of Colorado, A Body Corporate ENZYME REPLACEMENT THERAPY OPTIMIZATION FOR THE TREATMENT OF HOMOCYSTINURIA
MX2020004151A (es) 2017-10-30 2020-08-13 Takeda Pharmaceuticals Co Detergentes compatibles con el medio ambiente para la inactivacion de virus envueltos en lipidos.
WO2022133973A1 (en) 2020-12-25 2022-06-30 Guangzhou Bioseal Biotech Co., Ltd. Fibrinogen aseptic filtration
IL310285A (en) 2021-08-13 2024-03-01 Biotest Ag Fibrinogen preparations and preparation methods
CN119804367A (zh) * 2024-11-22 2025-04-11 重庆永仁心医疗器械有限公司 一种基于a280吸光度的纤维蛋白原浓度测试方法及应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2618784B1 (fr) 1987-07-30 1990-04-06 Lille Transfusion Sanguine Concentre de proteines coagulables par la thrombine, son procede d'obtention et son utilisation a titre de colle biologique
US5445958A (en) * 1987-12-22 1995-08-29 National Blood Authority Process for purifying blood clotting factors
JPH02193913A (ja) 1989-01-20 1990-07-31 Denki Kagaku Kogyo Kk パイロジエンを除去する方法
US5169936A (en) 1989-04-14 1992-12-08 Biogen, Inc. Protein purification on immobilized metal affinity resins effected by elution using a weak ligand
US5792835A (en) * 1991-09-05 1998-08-11 Baxter International Inc. Method of preparing a topical fibrinogen complex
WO1994002183A1 (en) 1992-07-27 1994-02-03 Haemacure Biotech Inc. Biocompatible surgical implant
JPH06138127A (ja) 1992-10-26 1994-05-20 Tanabe Seiyaku Co Ltd 標識フィブリノーゲンおよびその用途
US5395923A (en) 1993-02-23 1995-03-07 Haemacure-Biotech, Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out"
AU695266B2 (en) 1994-03-18 1998-08-13 Baxter International Inc. Topical fibrinogen complex
JPH0812586A (ja) 1994-07-01 1996-01-16 Mikimoto Pharmaceut Co Ltd 抗プラスミン剤
GB9424732D0 (en) 1994-12-08 1995-02-08 Common Services Agency Heat treated blood plasma proteins
JPH08333387A (ja) 1995-06-12 1996-12-17 Mitsubishi Materials Corp タンパク質分離精製方法
US6268487B1 (en) * 1996-05-13 2001-07-31 Genzyme Transgenics Corporation Purification of biologically active peptides from milk
GB9722131D0 (en) 1997-10-20 1997-12-17 Medical Res Council Method
US5981254A (en) 1997-10-30 1999-11-09 Haemacure Corporation Process for producing thrombin from plasma
AUPP521298A0 (en) 1998-08-12 1998-09-03 Life Therapeutics Limited Purification of fibrinogen
JP2001270900A (ja) 2000-03-23 2001-10-02 Nihon Pharmaceutical Co Ltd フィブリノゲンのウイルス不活化法

Also Published As

Publication number Publication date
BR0312521A (pt) 2005-04-19
ES2332780T3 (es) 2010-02-12
US7816495B2 (en) 2010-10-19
AU2003244850B2 (en) 2009-06-25
EP1519944B1 (en) 2009-11-18
WO2004007533A1 (en) 2004-01-22
PL210616B1 (pl) 2012-02-29
CA2491716A1 (en) 2004-01-22
MXPA05000395A (es) 2005-09-30
ECSP055584A (es) 2005-07-06
US20070042944A1 (en) 2007-02-22
ATE449104T1 (de) 2009-12-15
JP4324102B2 (ja) 2009-09-02
IL165988A0 (en) 2006-01-15
JP2006505508A (ja) 2006-02-16
CA2491716C (en) 2012-02-07
GB0216001D0 (en) 2002-08-21
NO20050091L (no) 2005-04-06
AU2003244850A1 (en) 2004-02-02
PL374080A1 (en) 2005-09-19
BRPI0312521B8 (pt) 2021-05-25
DE60330146D1 (de) 2009-12-31
BRPI0312521B1 (pt) 2019-06-25
EP1519944A1 (en) 2005-04-06

Similar Documents

Publication Publication Date Title
DK1519944T3 (da) Fremgangsmåder til fremstilling af fibrinogen
NO20091976L (no) Nye forbindelser
DK1633697T3 (da) Fremgangsmåde til fremstilling af substituerede 3-aryl-butyl-aminforbindelser
DE602004006433D1 (de) Pyrrol-substituierte indole als inhibitoren von pai-1
TWI265927B (en) Novel compounds as NS3-serine protease inhibitors of hepatitis C virus
EA200601555A1 (ru) Замещенные индазол-о-глюкозиды
EA200601554A1 (ru) Замещенные индол-о-глюкозиды
ATE289640T1 (de) Amidofunktionelle aminopolydiorganosiloxane
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
DE60107687D1 (de) Cyclpentanoindole, mischungen derartige verbindungen enthaltend und behandlungsmethoden
ATE412649T1 (de) Substituierte heteroarylbenzofuransäuren
BRPI0411897A (pt) pirroldihidroisoquinolinas como inibidores de pde10
TW200519089A (en) Biaryl sulfonamides and methods for using same
SE0301653D0 (sv) Novel compounds
ATE274348T1 (de) Überbrückte indenopyrrolocarbazole
ATE497492T1 (de) Reinigung von montelukast
TW200519100A (en) Biaryl sulfonamides and methods for using same
DK1456212T3 (da) 6-aminomorphinanderivater, fremgangsmåder til fremstilling heraf og disses anvendelse
NO20063196L (no) Nye fusjonerte pyrrolokarbazoler
ATE344321T1 (de) Verfahren zur aufreinigung von bakterienzellen und zellbestandteilen
ATE549024T1 (de) Chinazolin-kaliumkanalhemmer
DK1383742T3 (da) Syntese og fremgangsmåder til anvendelse af tetrahydroindolonanaloge og derivater
DE50205466D1 (de) Substituierte 2,5-diamidoindole als ece-inhibitoren zur behandlung von kardiovaskulären erkrankungen
DE60316128D1 (de) N-sulfonylurea-apoptosis-förderer
TR200402030T4 (tr) İkame edilen I-aminobutan-3-ol-türevleri